Selecting ADMET models for Drug Discovery
Recording of July 2017 AMG Global Health Compound Design webinar presented by Mark Gardner, AMG Consultants who discussed the process of selecting the most appropriate models for drug discovery projects from the pool of available free tools this Wednesday. His talk will cover
(a) comparing models with measured data and judging whether correlations are significant
(b) when specific models might (or might not) be more useful than logP
(c) the impact of tautomers
(d) sources of free models.
A copy of the slides is available from the MMV website (www.mmv.org)
